Canada markets closed

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.22-0.07 (-0.75%)
At close: 04:00PM EDT
9.22 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-236,923
-246,416
-221,102
-165,164
-81,355
Depreciation & amortization
8,789
8,277
6,075
4,484
1,025
Stock based compensation
43,422
46,547
44,710
25,873
8,454
Change in working capital
-4,737
-6,693
155,170
6,447
2,045
Accounts Payable
52
-992
-3,002
652
2,198
Other working capital
-194,579
-204,612
-16,059
-138,226
-85,383
Other non-cash items
14,714
15,194
12,007
2,754
1,973
Net cash provided by operating activites
-183,651
-192,231
-5,853
-124,982
-67,881
Cash flows from investing activities
Investments in property, plant and equipment
-10,928
-12,381
-10,206
-13,244
-17,502
Purchases of investments
-330,554
-365,039
-540,022
-128,705
-207,986
Sales/Maturities of investments
348,664
445,775
324,584
157,410
283,777
Net cash used for investing activites
7,182
68,355
-225,644
15,461
58,289
Cash flows from financing activities
Common stock issued
-
113,564
217,987
0
215,691
Common stock repurchased
-
-
-
-
0
Other financing activites
-
-
-
-1,555
-1,731
Net cash used privided by (used for) financing activities
115,145
115,068
219,382
2,476
214,781
Net change in cash
-61,324
-8,808
-12,115
-107,045
205,189
Cash at beginning of period
140,822
121,920
134,035
241,080
35,891
Cash at end of period
79,498
113,112
121,920
134,035
241,080
Free Cash Flow
Operating Cash Flow
-183,651
-192,231
-5,853
-124,982
-67,881
Capital Expenditure
-10,928
-12,381
-10,206
-13,244
-17,502
Free Cash Flow
-194,579
-204,612
-16,059
-138,226
-85,383